Global Intellectual Property Center

Tag Archives: TPP

2015 Global #IPSummit: Illuminating the Possibilities

2015 Global #IPSummit: Illuminating the Possibilities

U.S. Senate Finance Committee Chairman Orrin G. Hatch (R-UT) gives the Summit’s Friday morning keynote address. By Matt Harakal What brought a crowd of over 500 leading innovators, government officials, and industry association leaders to the U.S. Chamber recently? GIPC’s 3rd Annual Global IP Summit brought in guests from as far as China to as […]

Obama: Raise the Bar for Trade

Obama: Raise the Bar for Trade

Earlier today President Obama offered insight into the motivation behind pursuing free trade agreements. With two massive trade deals on the table—the Asia-Pacific Trans-Pacific Partnership (TPP) Agreement and the U.S.-EU Transatlantic Trade and Investment Partnership (TTIP)—the stakes for American business are even higher, especially as globalization continues to pose opportunities as well as challenges in […]

Tags: ,

Under the Microscope: Biologics Fight Highlights Importance of Stronger IP in Asia

Under the Microscope: Biologics Fight Highlights Importance of Stronger IP in Asia

When the 12 Asia-Pacific nations involved in Trans-Pacific Partnership (TPP) negotiations reached an impasse last month after week-long talks in Maui, one of the critical remaining points of disagreement was the trade agreement’s prospective coverage of intellectual property. As these talks have drawn on over a period of several years, bright lines have emerged between […]

Tags: ,

TPP an Opportunity to Promote Global Innovation and Creativity

TPP an Opportunity to Promote Global Innovation and Creativity

By Patrick Kilbride As negotiations for a Trans-Pacific Partnership (TPP) head toward a potential conclusion this week in Maui, the U.S. Chamber of Commerce’s Global IP Center reminds policy makers of the critical importance of innovative and creative industries to American jobs, growth, and future economic success. Innovation supported by intellectual property rules provides 40 […]

Getting the Facts Straight: Access to Medicines and the TPP

Getting the Facts Straight: Access to Medicines and the TPP

It’s ironic that today’s life-saving medicines often resemble modern miracles while the biopharmaceutical companies that create them draw the ire of activist groups. This drama is playing out again in the context of the Trans-Pacific Partnership (TPP).